Pius Maliakal

Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.

Mao‐Jung Lee, Pius Maliakal, Laishun Chen et al. · PubMed · 2002 · 721 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Jennifer R. Diamond et al. · Journal of Clinical Oncology · 2017 · 409 citations

Medicine, Oncology, Pharmacology +12

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

Aditya Bardia, Wells A. Messersmith, Ebenezer A. Kio et al. · Annals of Oncology · 2021 · 375 citations

Medicine, Oncology, Pharmacology +17

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

Alexander Starodub, Allyson J. Ocean, Manish A. Shah et al. · Clinical Cancer Research · 2015 · 344 citations · Full text

Medicine, Oncology, Pharmacology +17

Urinary and Plasma Levels of Resveratrol and Quercetin in Humans, Mice, and Rats after Ingestion of Pure Compounds and Grape Juice

Xiaofeng Meng, Pius Maliakal, Hong Lu et al. · Journal of Agricultural and Food Chemistry · 2004 · 284 citations

Agriculture, Pharmacokinetics, Pharmacology +6